SNOANasdaq United States
Market cap
$6.895 M
$1.44 +15.20%
Close of 7 Aug 2026
Revenue
$19.5M
#3005 by revenue
Earnings
$3.17K
#2485 by earnings
Shares outstanding
4,785,801
Latest filing cover page
P/E ratio
2171.8
Cap ÷ net income
Where these numbers come from
Share counts and financials for Sonoma Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.